Biopharma’s correction? 2022 1Q investments are both up and down
Release Date:
BioWorld Senior Analyst Karen Carey explores the newest data and where it is leading. Hosted on Acast. See acast.com/privacy for more information.
Biopharma’s correction? 2022 1Q investments are both up and down